175 related articles for article (PubMed ID: 19556880)
1. Vascular endothelial growth factor receptor-3 promotes breast cancer cell proliferation, motility and survival in vitro and tumor formation in vivo.
Kurenova EV; Hunt DL; He D; Fu AD; Massoll NA; Golubovskaya VM; Garces CA; Cance WG
Cell Cycle; 2009 Jul; 8(14):2266-80. PubMed ID: 19556880
[TBL] [Abstract][Full Text] [Related]
2. Hypoxia-induced epithelial VEGF-C/VEGFR-3 upregulation in carcinoma cell lines.
Simiantonaki N; Jayasinghe C; Michel-Schmidt R; Peters K; Hermanns MI; Kirkpatrick CJ
Int J Oncol; 2008 Mar; 32(3):585-92. PubMed ID: 18292935
[TBL] [Abstract][Full Text] [Related]
3. RNAi-mediated silencing of VEGF-C inhibits non-small cell lung cancer progression by simultaneously down-regulating the CXCR4, CCR7, VEGFR-2 and VEGFR-3-dependent axes-induced ERK, p38 and AKT signalling pathways.
Feng Y; Hu J; Ma J; Feng K; Zhang X; Yang S; Wang W; Zhang J; Zhang Y
Eur J Cancer; 2011 Oct; 47(15):2353-63. PubMed ID: 21680174
[TBL] [Abstract][Full Text] [Related]
4. The vascular endothelial growth factor receptor (VEGFR-1) supports growth and survival of human breast carcinoma.
Wu Y; Hooper AT; Zhong Z; Witte L; Bohlen P; Rafii S; Hicklin DJ
Int J Cancer; 2006 Oct; 119(7):1519-29. PubMed ID: 16671089
[TBL] [Abstract][Full Text] [Related]
5. Vascular endothelial growth factor receptor-1 activation promotes migration and invasion of breast cancer cells through epithelial-mesenchymal transition.
Ning Q; Liu C; Hou L; Meng M; Zhang X; Luo M; Shao S; Zuo X; Zhao X
PLoS One; 2013; 8(6):e65217. PubMed ID: 23776453
[TBL] [Abstract][Full Text] [Related]
6. Endothelin-1 induces the transactivation of vascular endothelial growth factor receptor-3 and modulates cell migration and vasculogenic mimicry in melanoma cells.
Spinella F; Caprara V; Di Castro V; Rosanò L; Cianfrocca R; Natali PG; Bagnato A
J Mol Med (Berl); 2013 Mar; 91(3):395-405. PubMed ID: 22965194
[TBL] [Abstract][Full Text] [Related]
7. Direct recruitment of CRK and GRB2 to VEGFR-3 induces proliferation, migration, and survival of endothelial cells through the activation of ERK, AKT, and JNK pathways.
Salameh A; Galvagni F; Bardelli M; Bussolino F; Oliviero S
Blood; 2005 Nov; 106(10):3423-31. PubMed ID: 16076871
[TBL] [Abstract][Full Text] [Related]
8. VEGF-C promotes the development of esophageal cancer via regulating CNTN-1 expression.
Liu P; Zhou J; Zhu H; Xie L; Wang F; Liu B; Shen W; Ye W; Xiang B; Zhu X; Shi R; Zhang S
Cytokine; 2011 Jul; 55(1):8-17. PubMed ID: 21482472
[TBL] [Abstract][Full Text] [Related]
9. ZD6474, a dual tyrosine kinase inhibitor of EGFR and VEGFR-2, inhibits MAPK/ERK and AKT/PI3-K and induces apoptosis in breast cancer cells.
Sarkar S; Mazumdar A; Dash R; Sarkar D; Fisher PB; Mandal M
Cancer Biol Ther; 2010 Apr; 9(8):592-603. PubMed ID: 20139705
[TBL] [Abstract][Full Text] [Related]
10. RING1 and YY1 binding protein suppresses breast cancer growth and metastasis.
Zhou H; Li J; Zhang Z; Ye R; Shao N; Cheang T; Wang S
Int J Oncol; 2016 Dec; 49(6):2442-2452. PubMed ID: 27748911
[TBL] [Abstract][Full Text] [Related]
11. Vascular endothelial growth factor receptor-3 and focal adhesion kinase bind and suppress apoptosis in breast cancer cells.
Garces CA; Kurenova EV; Golubovskaya VM; Cance WG
Cancer Res; 2006 Feb; 66(3):1446-54. PubMed ID: 16452200
[TBL] [Abstract][Full Text] [Related]
12. The tyrosine kinase inhibitor cediranib blocks ligand-induced vascular endothelial growth factor receptor-3 activity and lymphangiogenesis.
Heckman CA; Holopainen T; Wirzenius M; Keskitalo S; Jeltsch M; Ylä-Herttuala S; Wedge SR; Jürgensmeier JM; Alitalo K
Cancer Res; 2008 Jun; 68(12):4754-62. PubMed ID: 18559522
[TBL] [Abstract][Full Text] [Related]
13. Acylglycerol kinase promotes cell proliferation and tumorigenicity in breast cancer via suppression of the FOXO1 transcription factor.
Wang X; Lin C; Zhao X; Liu A; Zhu J; Li X; Song L
Mol Cancer; 2014 May; 13():106. PubMed ID: 24886245
[TBL] [Abstract][Full Text] [Related]
14. MiR-507 inhibits the migration and invasion of human breastcancer cells through Flt-1 suppression.
Jia L; Liu W; Cao B; Li H; Yin C
Oncotarget; 2016 Jun; 7(24):36743-36754. PubMed ID: 27167339
[TBL] [Abstract][Full Text] [Related]
15. MiR-410 Acts as a Tumor Suppressor in Estrogen Receptor-Positive Breast Cancer Cells by Directly Targeting ERLIN2 via the ERS Pathway.
Wu H; Li J; Guo E; Luo S; Wang G
Cell Physiol Biochem; 2018; 48(2):461-474. PubMed ID: 30016800
[TBL] [Abstract][Full Text] [Related]
16. High Glucose Promotes Epithelial-Mesenchymal Transition of Uterus Endometrial Cancer Cells by Increasing ER/GLUT4-Mediated VEGF Secretion.
Gu CJ; Xie F; Zhang B; Yang HL; Cheng J; He YY; Zhu XY; Li DJ; Li MQ
Cell Physiol Biochem; 2018; 50(2):706-720. PubMed ID: 30308493
[TBL] [Abstract][Full Text] [Related]
17. The pathological roles and potential mechanisms of vascular endothelial growth factor receptor-3 in gastric cancer.
Li XF; Zhang XJ; Hao FR; Dong XT; Xu GD; Zhang YX
J Int Med Res; 2024 Mar; 52(3):3000605241234558. PubMed ID: 38518198
[TBL] [Abstract][Full Text] [Related]
18. Tubular network formation by adriamycin-resistant MCF-7 breast cancer cells is closely linked to MMP-9 and VEGFR-2/VEGFR-3 over-expressions.
Karroum A; Mirshahi P; Faussat AM; Therwath A; Mirshahi M; Hatmi M
Eur J Pharmacol; 2012 Jun; 685(1-3):1-7. PubMed ID: 22542663
[TBL] [Abstract][Full Text] [Related]
19. Protein kinase D1 stimulates proliferation and enhances tumorigenesis of MCF-7 human breast cancer cells through a MEK/ERK-dependent signaling pathway.
Karam M; Legay C; Auclair C; Ricort JM
Exp Cell Res; 2012 Mar; 318(5):558-69. PubMed ID: 22245102
[TBL] [Abstract][Full Text] [Related]
20. Activation of vascular endothelial growth factor receptor-3 and its downstream signaling promote cell survival under oxidative stress.
Wang JF; Zhang X; Groopman JE
J Biol Chem; 2004 Jun; 279(26):27088-97. PubMed ID: 15102829
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]